Loss of HIV-infected patients on potent antiretroviral therapy programs in Togo: Risk factors and the fate of these patients

Pan African Medical Journal

Volumn 15, Issue , 2013, Pages

  Saka, Bayaki ^a   Landoh, Dadja Essoya ^b   Patassi, Akouda ^a   d'Almeida, Stephane ^b   Singo, Assetina ^b   Gessner, Bradford D ^c   Pitché, Palokinam Vincent ^a,b  

^a UNIVERSITÉ DE LOMÉ   (Togo)

^b MINISTÈRE DE LA SANTÉ   (Togo)

^c Agence de Medecine Preventive   (France)

Author keywords

Africa; HIV; Human immunodeficiency virus; Lost to follow up; People living with HIV; Togo

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACCESS TO INFORMATION; ADULT; AGE; ARTICLE; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH CARE FACILITY; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MORTALITY; OPPORTUNISTIC INFECTION; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; RISK FACTOR; SEX; TOGO; AFRICA; AIDS RELATED COMPLEX; HUMAN IMMUNODEFICIENCY VIRUS; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PEOPLE LIVING WITH HIV; PUBLIC HEALTH; SEX DIFFERENCE; STATISTICS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CLINICAL TRIAL; HIV INFECTIONS; STATISTICS AND NUMERICAL DATA;

AFRICA; HIV; HUMAN IMMUNODEFICIENCY VIRUS; LOST TO FOLLOW-UP; PEOPLE LIVING WITH HIV; TOGO;

ADULT; AGE FACTORS; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; LOST TO FOLLOW-UP; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NATIONAL HEALTH PROGRAMS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; TOGO;

EID: 84887423250     PISSN: 19378688     EISSN: None     Source Type: Journal    
DOI: 10.11604/pamj.2013.15.35.2198     Document Type: Article

References (21)

1. Programme national de Lutte contre le SIDA et les infections sexuellement transmissibles (PNLS/IST): Rapport d?activités. 2009. Google Scholar
2. Ekouevi DK, Balestre E, Ba-Gomis FO, Eholie SP, Maiga M, et al. Low retention of HIV-infected patients on antiretroviral therapy in 11 clinical centres in West Africa. Trop Med Int Health. 2010 Jun;15 Suppl 1:34-42. PubMed | Google Scholar
3. Fox MP, Rosen S. Patient retention in antiretroviral therapy programs up to three years on treatment in sub-Saharan Africa, 2007-2009: systematic review. Trop Med Int Health. 2010 Jun;15 Suppl 1:1-15. PubMed | Google Scholar
4. Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008 Jul;86(7):559-67. PubMed | Google Scholar
5. Lebouche B, Yazdanpanah Y, Gerard Y, Sissoko D, Ajana F, et al. Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998. HIV Med. 2006 Apr;7(3):140-5. PubMed | Google Scholar
6. Zwahlen M, Harris R, May M, Hogg R, Costagliola D, et al. Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol. 2009 Dec;38(6):1624-33. PubMed | Google Scholar
7. Schoni-Affolter F, Keiser O, Mwango A, Stringer J, Ledergerber B, et al. Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and Switzerland. PLoS One. 2011;6(12):e27919. PubMed | Google Scholar
8. Chi BH, Cantrell RA, Mwango A, Westfall AO, Mutale W, et al. An empirical approach to defining loss to follow-up among patients enrolled in antiretroviral treatment programs. Am J Epidemiol. 2010 Apr 15;171(8):924-31. PubMed | Google Scholar
9. Braitstein P, Brinkhof MW, Dabis F, Schechter M, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2006 Mar 11;367(9513):817-24. PubMed | Google Scholar
10. Chi BH, Yiannoutsos CT, Westfall AO, Newman JE, et al. Universal definition of loss to follow-up in HIV treatment programs: a statistical analysis of 111 facilities in Africa, Asia, and Latin America. PLoS Med. 2011; 8:e1001111. PubMed | Google Scholar
11. Balogou AA, Saka B, Kombate D, Kombate K, Mouhari-Toure A, et al. Causes of mortality associated with HIV/AIDS in health-care facilities in Togo: a six-month prospective study. Trop Doct. 2011 Oct;41(4):215-7. PubMed | Google Scholar
12. Toure S, Kouadio B, Seyler C, Traore M, Dakoury-Dogbo N, et al. Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote d'Ivoire: 2-year outcomes and determinants. AIDS. 2008 Apr 23;22(7):873-82. PubMed | Google Scholar
13. Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. 2006 Aug 16;296(7):782-93. PubMed | Google Scholar
14. Sani MU, Mohammed AZ, Adamu B, Yusuf SM, et al. AIDS mortality in a tertiary health institution: A four-year review. J Natl Med Assoc. 2006 Jun;98(6):862-6. PubMed | Google Scholar
15. Ansari NA, Kombe AH, Kenyon TA, Hone NM, et al. Pathology and causes of death in a group of 128 predominantly HIV-positive patients in Botswana, 1997-1998. Int J Tuberc Lung Dis. 2002 Jan;6(1):55-63. PubMed | Google Scholar
16. Roura M, Busza J, Wringe A, Mbata D, Urassa M, Zaba B. Barriers to sustaining antiretroviral treatment in Kisesa, Tanzania: a follow-up study to understand attrition from the antiretroviral program. AIDS Patient Care STDS. 2009 Mar;23(3):203-10. PubMed | Google Scholar
17. Dalal RP, Macphail C, Mqhayi M, Wing J, Feldman C, Chersich MF, Venter WD. Characteristics and outcomes of adult patients lost to follow-up at an antiretroviral treatment clinic in johannesburg, South Africa. J Acquir Immune Defic Syndr. 2008 Jan 1;47(1):101-7. PubMed | Google Scholar
18. Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, Schouten EJ, Harries AD. True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi. Bull World Health Organ. 2007 Jul;85(7):550-4. PubMed | Google Scholar
19. Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS One. 2009 Jun 4;4(6):e5790. PubMed | Google Scholar
20. Mbuagbaw L, Bonono-Momnougui RC, Thabane L. Considerations in using text messages to improve adherence to highly active antiretroviral therapy: a qualitative study among clients in Yaounde, Cameroon. HIV AIDS (Auckl). 2012;4:45-50. PubMed | Google Scholar
21. Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet. 2010 Nov 27;376(9755):1838-45. PubMed | Google Scholar